Abstract
Bone metastases are associated with high level of morbidity and compromised quality of life .It often leads to wide variety of unpleasant or sometimes life threatening complications. The probability of bone metastasis originating from a primary site can be assessed only by knowing the prevalence of the cancer in that community and its predilection for bone. Therefore, the frequency of bone metastases depends on the prevalence of the cancer in a particular community. Investigations most commonly include 99mTc radionuclide bone scan. It is regarded as the most cost-effective and available whole-body screening test for the assessment of bone metastases. Bone metastases can present to different specialties and the success of treatment depends on the coordination between multiple disciplines. The team approach should be always considered. Surgery, external radiation, radioactive pharmaceuticals, bisphosphonates and chemotherapy all are reasonable treatment options and should individualized as per clinical picture.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Internet Journal of Pain, Symptom Control and Palliative Care
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
